Formyl peptide receptors at the interface of inflammation, angiogenesis and tumor growth

Pharmacological Research

Volumn 102, Issue , 2015, Pages 184-191

  Prevete, Nella ^a   Liotti, Federica ^a,b   Marone, Gianni ^a,b   Melillo, Rosa Marina ^a,b   De Paulis, Amato ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b CNR   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; BACTERIAL PROTEIN; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; CATHEPSIN G; CHENODEOXYCHOLIC ACID; CYCLOSPORIN H; DEOXYCHOLIC ACID; FORMYLPEPTIDE RECEPTOR; FORMYLPEPTIDE RECEPTOR 1; FORMYLPEPTIDE RECEPTOR 1 AGONIST; FORMYLPEPTIDE RECEPTOR 2; FORMYLPEPTIDE RECEPTOR 2 AGONIST; FORMYLPEPTIDE RECEPTOR 3; FORMYLPEPTIDE RECEPTOR 3 AGONIST; FORMYLPEPTIDE RECEPTOR AGONIST; HP(2-20) PEPTIDE; LIGAND; LIPOCORTIN 1; LIPOXIN A; LIPOXYGENASE; METHIONYLMETHIONYLTRYPTOPHYLLEUCYLLEUCINE; PROTEIN HEBP1; PROTEIN UPAR; RESOLVIN D1; SERUM AMYLOID A; SPINORPHIN; TRYPTOPHYLLYSYLTYROSYLMETHIONYLVALYLMETHIONINE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BINDING AFFINITY; CARCINOGENESIS; CELLULAR DISTRIBUTION; CORNEA NEOVASCULARIZATION; GASTRIC MUCOSA; GENE SILENCING; HOST RESISTANCE; HUMAN; IMMUNOMODULATION; IMMUNOREACTIVITY; INFLAMMATION; INFLAMMATORY ANGIOGENESIS; LEUKOCYTE MIGRATION; MELANOMA; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; STOMACH CANCER; TISSUE REPAIR; TUMOR GROWTH; TUMOR VASCULARIZATION; WOUND HEALING; METABOLISM; NEOPLASM; PATHOLOGY; PHYSIOLOGY;

HUMANS; INFLAMMATION; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; RECEPTORS, FORMYL PEPTIDE; WOUND HEALING;

EID: 84944715423     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2015.09.017     Document Type: Review

References (74)

1. P. Broz, and D.M. Monack Newly described pattern recognition receptors team up against intracellular pathogens Nat. Rev. Immunol. 13 2013 551 565
2. I. Migeotte, D. Communi, and M. Parmentier Formyl peptide receptors: a promiscuous subfamily of G protein-coupled receptors controlling immune responses Cytokine Growth Factor Rev. 17 2006 501 519
3. R.D. Ye, F. Boulay, J.M. Wang, C. Dahlgren, C. Gerard, M. Parmentier, and et al. International union of basic and clinical pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family Pharmacol. Rev. 61 2009 119 161
4. G.M. Bokoch, and A.G. Gilman Inhibition of receptor-mediated release of arachidonic acid by pertussis toxin Cell 39 1984 301 308
5. G.M. Bokoch, T. Katada, J.K. Northup, M. Ui, and A.G. Gilman Purification and properties of the inhibitory guanine nucleotide-binding regulatory component of adenylate cyclase J. Biol. Chem. 259 1984 3560 3567
6. P. Gierschik, D. Sidiropoulos, and K.H. Jakobs Two distinct Gi-proteins mediate formyl peptide receptor signal transduction in human leukemia (HL-60) cells J. Biol. Chem. 264 1989 21470 21473
7. P.M. Lad, B.J. Goldberg, P.A. Smiley, and C.V. Olson Receptor-specific threshold effects of cyclic AMP are involved in the regulation of enzyme release and superoxide production from human neutrophils Biochim. Biophys. Acta 846 1985 286 295
8. R.I. Sha'afi, and T.F. Molski Activation of the neutrophil Prog. Allergy. 42 1988 1 64
9. M.I. Simon, M.P. Strathmann, and N. Gautam Diversity of G proteins in signal transduction Science 252 1991 802 808
10. M.J. Rabiet, E. Huet, and F. Boulay Human mitochondria-derived N-formylated peptides are novel agonists equally active on FPR and FPRL1, while Listeria monocytogenes-derived peptides preferentially activate FPR Eur. J. Immunol. 35 2005 2486 2495
11. R.D. Ye, S.L. Cavanagh, O. Quehenberger, E.R. Prossnitz, and C.G. Cochrane Isolation of a cDNA that encodes a novel granulocyte N-formyl peptide receptor Biochem. Biophys. Res. Commun. 184 1992 582 589
12. N. Dufton, and M. Perretti Therapeutic anti-inflammatory potential of formyl-peptide receptor agonists Pharmacol. Ther. 127 2010 175 188
13. A. de Paulis, A. Ciccarelli, G. de Crescenzo, R. Cirillo, V. Patella, and G. Marone Cyclosporin H is a potent and selective competitive antagonist of human basophil activation by N-formyl-methionyl-leucyl-phenylalanine J. Allergy Clin. Immunol. 98 1996 152 164
14. K. Wenzel-Seifert, L. Grunbaum, and R. Seifert Differential inhibition of human neutrophil activation by cyclosporins A D, and H. Cyclosporin H is a potent and effective inhibitor of formyl peptide-induced superoxide formation J. Immunol. 147 1991 1940 1946
15. Y. Le, P.M. Murphy, and J.M. Wang Formyl-peptide receptors revisited Trends Immunol. 23 2002 541 548
16. D. El Kebir, L. Jozsef, and J.G. Filep Opposing regulation of neutrophil apoptosis through the formyl peptide receptor-like 1/lipoxin A4 receptor: implications for resolution of inflammation J. Leukoc. Biol. 84 2008 600 606
17. P. Maderna, and C. Godson Taking insult from injury: lipoxins and lipoxin receptor agonists and phagocytosis of apoptotic cells Prostaglandins Leukot. Essent. Fatty Acids 73 2005 179 187
18. M. Scannell, M.B. Flanagan, A. deStefani, K.J. Wynne, G. Cagney, C. Godson, and et al. Annexin-1 and peptide derivatives are released by apoptotic cells and stimulate phagocytosis of apoptotic neutrophils by macrophages J. Immunol. 178 2007 4595 4605
19. M. Perretti, and F. D'Acquisto Annexin A1 and glucocorticoids as effectors of the resolution of inflammation Nat. Rev. Immunol. 9 2009 62 70
20. C.N. Serhan Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways Annu. Rev. Immunol. 25 2007 101 137
21. F. D'Acquisto, M. Perretti, and R.J. Flower Annexin-A1: a pivotal regulator of the innate and adaptive immune systems Br. J. Pharmacol. 155 2008 152 169
22. T. Devosse, A. Guillabert, N. D'Haene, A. Berton, P. De Nadai, S. Noel, and et al. Formyl peptide receptor-like 2 is expressed and functional in plasmacytoid dendritic cells, tissue-specific macrophage subpopulations, and eosinophils J. Immunol. 182 2009 4974 4984
23. E.L. Becker, F.A. Forouhar, M.L. Grunnet, F. Boulay, M. Tardif, B.J. Bormann, and et al. Broad immunocytochemical localization of the formylpeptide receptor in human organs, tissues, and cells Cell Tissue Res. 292 1998 129 135
24. F. Cattaneo, G. Guerra, M. Parisi, A. Lucariello, A. De Luca, N. De Rosa, and et al. Expression of Formyl-peptide receptors in human lung carcinoma Anticancer. Res. 35 2015 2769 2774
25. A. de Paulis, N. Prevete, F.W. Rossi, F. Rivellese, F. Salerno, G. Delfino, and et al. Helicobacter pylori Hp(2-20) promotes migration and proliferation of gastric epithelial cells by interacting with formyl peptide receptors in vitro and accelerates gastric mucosal healing in vivo J. Immunol. 183 2009 3761 3769
26. M. Harada, Y. Habata, M. Hosoya, K. Nishi, R. Fujii, M. Kobayashi, and et al. N-Formylated humanin activates both formyl peptide receptor-like 1 and 2 Biochem. Biophys. Res. Commun. 324 2004 255 261
27. G. Shao, M.W. Julian, S. Bao, M.K. McCullers, J.P. Lai, D.L. Knoell, and et al. Formyl peptide receptor ligands promote wound closure in lung epithelial cells Am. J. Respir. Cell. Mol. Biol. 44 2011 264 269
28. S.E. VanCompernolle, K.L. Clark, K.A. Rummel, and S.C. Todd Expression and function of formyl peptide receptors on human fibroblast cells J. Immunol. 171 2003 2050 2056
29. Y. Li, and D. Ye Molecular biology for formyl peptide receptors in human diseases J. Mol. Med. (Berl.) 91 2013 781 789
30. B.A. Babbin, A.J. Jesaitis, A.I. Ivanov, D. Kelly, M. Laukoetter, P. Nava, and et al. Formyl peptide receptor-1 activation enhances intestinal epithelial cell restitution through phosphatidylinositol 3-kinase-dependent activation of Rac1 and Cdc42 J. Immunol. 179 2007 8112 8121
31. N. Prevete, F.A. Salzano, F.W. Rossi, F. Rivellese, M. Dellepiane, L. Guastini, and et al. Role(s) of formyl-peptide receptors expressed in nasal epithelial cells J. Biol. Regul. Homeost. Agents 25 2011 553 564
32. X.G. Zhang, Y.N. Hui, X.F. Huang, H.J. Du, J. Zhou, and J.X. Ma Activation of formyl peptide receptor-1 enhances restitution of human retinal pigment epithelial cell monolayer under electric fields Invest. Ophthalmol. Vis. Sci. 52 2011 3160 3165
33. J. Pott, and M. Hornef Innate immune signalling at the intestinal epithelium in homeostasis and disease EMBO Rep. 13 2012 684 698
34. A. Alam, G. Leoni, C.C. Wentworth, J.M. Kwal, H. Wu, C.S. Ardita, and et al. Redox signaling regulates commensal-mediated mucosal homeostasis and restitution and requires formyl peptide receptor 1 Mucosal. Immunol. 7 2014 645 655
35. K. Chen, M. Liu, Y. Liu, T. Yoshimura, W. Shen, Y. Le, and et al. Formylpeptide receptor-2 contributes to colonic epithelial homeostasis, inflammation, and tumorigenesis J. Clin. Invest. 123 2013 1694 1704
36. S.A. Eming, T. Krieg, and J.M. Davidson Inflammation in wound repair: molecular and cellular mechanisms J. Invest. Dermatol. 127 2007 514 525
37. T. Velnar, T. Bailey, and V. Smrkolj The wound healing process: an overview of the cellular and molecular mechanisms J. Int. Med. Res. 37 2009 1528 1542
38. H. Brem, and M. Tomic-Canic Cellular and molecular basis of wound healing in diabetes J. Clin. Invest. 117 2007 1219 1222
39. M. Schafer, and S. Werner Cancer as an overhealing wound: an old hypothesis revisited Nat. Rev. Mol. Cell. Biol. 9 2008 628 638
40. F. Cerimele, L.F. Brown, F. Bravo, G.M. Ihler, P. Kouadio, and J.L. Arbiser Infectious angiogenesis: Bartonella bacilliformis infection results in endothelial production of angiopoetin-2 and epidermal production of vascular endothelial growth factor Am. J. Pathol. 163 2003 1321 1327
41. Y. De, Q. Chen, A.P. Schmidt, G.M. Anderson, J.M. Wang, J. Wooters, and et al. LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells J. Exp. Med. 192 2000 1069 1074
42. R. Koczulla, G. von Degenfeld, C. Kupatt, F. Krotz, S. Zahler, T. Gloe, and et al. An angiogenic role for the human peptide antibiotic LL-37/hCAP-18 J. Clin. Invest. 111 2003 1665 1672
43. R.L. Meek, J.S. Hoffman, and E.P. Benditt Amyloidogenesis. One serum amyloid A isotype is selectively removed from the circulation J. Exp. Med. 163 1986 499 510
44. R.L. Meek, S. Urieli-Shoval, and E.P. Benditt Expression of apolipoprotein serum amyloid A mRNA in human atherosclerotic lesions and cultured vascular cells: implications for serum amyloid A function Proc. Natl. Acad. Sci. U. S. A. 91 1994 3186 3190
45. R.H. Mullan, B. Bresnihan, L. Golden-Mason, T. Markham, R. O'Hara, O. FitzGerald, and et al. Acute-phase serum amyloid A stimulation of angiogenesis, leukocyte recruitment, and matrix degradation in rheumatoid arthritis through an NF-kappaB-dependent signal transduction pathway Arthritis Rheum. 54 2006 105 114
46. M.S. Lee, S.A. Yoo, C.S. Cho, P.G. Suh, W.U. Kim, and S.H. Ryu Serum amyloid A binding to formyl peptide receptor-like 1 induces synovial hyperplasia and angiogenesis J. Immunol. 177 2006 5585 5594
47. S. Loffredo, R.I. Staiano, F. Granata, A. Genovese, and G. Marone Immune cells as a source and target of angiogenic and lymphangiogenic factors Chem. Immunol. Allergy. 99 2014 15 36
48. N. Prevete, F.W. Rossi, F. Rivellese, D. Lamacchia, C. Pelosi, A. Lobasso, and et al. Helicobacter pylori HP(2-20) induces eosinophil activation and accumulation in superficial gastric mucosa and stimulates VEGF-alpha and TGF-beta release by interacting with formyl-peptide receptors Int. J. Immunopathol. Pharmacol. 26 2013 647 662
49. F. Blasi, and P. Carmeliet uPAR: a versatile signalling orchestrator Nat. Rev. Mol. Cell. Biol. 3 2002 932 943
50. N. Montuori, and P. Ragno Role of uPA/uPAR in the modulation of angiogenesis Chem. Immunol. Allergy. 99 2014 105 122
51. B.R. Binder, J. Mihaly, and G.W. Prager uPAR-uPA-PAI-1 interactions and signaling: a vascular biologist's view Thromb. Haemost. 97 2007 336 342
52. M.S. Pepper, C. Rosnoblet, C. Di Sanza, and E.K. Kruithof Synergistic induction of t-PA by vascular endothelial growth factor and basic fibroblast growth factor and localization of t-PA to Weibel-Palade bodies in bovine microvascular endothelial cells Thromb. Haemost. 86 2001 702 709
53. K. Bifulco, I. Longanesi-Cattani, M. Gala, G. D.I.C, M.T. Masucci, V. Pavone, and et al. The soluble form of urokinase receptor promotes angiogenesis through its Ser(8)(8)-Arg-Ser-Arg-Tyr(9)(2) chemotactic sequence Thromb. Haemost. 8 2010 2789 2799
54. M. Resnati, I. Pallavicini, J.M. Wang, J. Oppenheim, C.N. Serhan, M. Romano, and et al. The fibrinolytic receptor for urokinase activates the G protein-coupled chemotactic receptor FPRL1/LXA4R Proc. Natl. Acad. Sci. U. S. A. 99 2002 1359 1364
55. A. de Paulis, N. Montuori, N. Prevete, I. Fiorentino, F.W. Rossi, V. Visconte, and et al. Urokinase induces basophil chemotaxis through a urokinase receptor epitope that is an endogenous ligand for formyl peptide receptor-like 1 and -like 2 J. Immunol. 173 2004 5739 5748
56. C.N. Serhan, N. Chiang, and T.E. Van Dyke Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators Nat. Rev. Immunol. 8 2008 349 361
57. C.N. Serhan, N. Chiang, and J. Dalli The resolution code of acute inflammation: novel pro-resolving lipid mediators in resolution Semin. Immunol. 27 2015 200 215
58. C.N. Serhan, S. Yacoubian, and R. Yang Anti-inflammatory and proresolving lipid mediators Annu. Rev. Pathol. 3 2008 279 312
59. J.L. Cash, L.V. Norling, and M. Perretti Resolution of inflammation: targeting GPCRs that interact with lipids and peptides Drug. Discov. Today. 19 2014 1186 1192
60. K. Gronert Lipoxins in the eye and their role in wound healing Prostaglandins Leukot. Essent. Fatty Acids. 73 2005 221 229
61. A.J. Leedom, A.B. Sullivan, B. Dong, D. Lau, and K. Gronert Endogenous LXA4 circuits are determinants of pathological angiogenesis in response to chronic injury Am. J. Pathol. 176 2010 74 84
62. L.V. Norling, J. Dalli, R.J. Flower, C.N. Serhan, and M. Perretti Resolvin D1 limits polymorphonuclear leukocyte recruitment to inflammatory loci: receptor-dependent actions Arterioscler. Thromb. Vasc. Biol. 32 2012 1970 1978
63. Y. Jin, M. Arita, Q. Zhang, D.R. Saban, S.K. Chauhan, N. Chiang, and et al. Anti-angiogenesis effect of the novel anti-inflammatory and pro-resolving lipid mediators Invest. Ophthalmol. Vis. Sci. 50 2009 4743 4752
64. F. Balkwill, and A. Mantovani Inflammation and cancer: back to Virchow? Lancet 357 2001 539 545
65. Y. Zhou, X. Bian, Y. Le, W. Gong, J. Hu, X. Zhang, and et al. Formylpeptide receptor FPR and the rapid growth of malignant human gliomas J. Natl. Cancer Inst. 97 2005 823 835
66. Y. Yang, Y. Liu, X. Yao, Y. Ping, T. Jiang, Q. Liu, and et al. Annexin 1 released by necrotic human glioblastoma cells stimulates tumor cell growth through the formyl peptide receptor 1 Am. J. Pathol. 179 2011 1504 1512
67. J.E. Jung, H.G. Lee, I.H. Cho, D.H. Chung, S.H. Yoon, Y.M. Yang, and et al. STAT3 is a potential modulator of HIF-1-mediated VEGF expression in human renal carcinoma cells FASEB J. 19 2005 1296 1298
68. G. Niu, K.L. Wright, M. Huang, L. Song, E. Haura, J. Turkson, and et al. Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis Oncogene 21 2002 2000 2008
69. J.C. Boer, U.M. Domanska, H. Timmer-Bosscha, I.G. Boer, C.J. de Haas, J.V. Joseph, and et al. Inhibition of formyl peptide receptor in high-grade astrocytoma by CHemotaxis Inhibitory Protein of S. aureus Br. J. Cancer 108 2013 587 596
70. N. Prevete, F. Liotti, C. Visciano, G. Marone, R.M. Melillo, and A. de Paulis The formyl peptide receptor 1 exerts a tumor suppressor function in human gastric cancer by inhibiting angiogenesis Oncogene 34 2015 3826 3838
71. T. Otani, S. Ikeda, H. Lwin, T. Arai, M. Muramatsu, and M. Sawabe Polymorphisms of the formylpeptide receptor gene (FPR1) and susceptibility to stomach cancer in 1531 consecutive autopsy cases Biochem. Biophys. Res. Commun. 405 2011 356 361
72. R. Seifert, and K. Wenzel-Seifert Defective Gi protein coupling in two formyl peptide receptor mutants associated with localized juvenile periodontitis J. Biol. Chem. 276 2001 42043 42049
73. Y. Chen, H. Hao, S. He, L. Cai, Y. Li, S. Hu, and et al. Lipoxin A4 and its analogue suppress the tumor growth of transplanted H22 in mice: the role of antiangiogenesis Mol. Cancer Ther. 9 2010 2164 2174
74. J. Liu, J. Li, X. Zeng, Z. Rao, J. Gao, B. Zhang, and et al. Formyl peptide receptor suppresses melanoma development and promotes NK cell migration Inflammation 37 2014 984 992